These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11751791)
1. Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. Agustí C; Pujol M; Argerich MJ; Ayats J; Badía M; Domínguez MA; Corbella X; Ariza J J Antimicrob Chemother; 2002 Jan; 49(1):205-8. PubMed ID: 11751791 [TBL] [Abstract][Full Text] [Related]
2. Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance. Sánchez-Ramírez C; Hípola-Escalada S; Cabrera-Santana M; Hernández-Viera MA; Caipe-Balcázar L; Saavedra P; Artiles-Campelo F; Sangil-Monroy N; Lübbe-Vázquez CF; Ruiz-Santana S Crit Care; 2018 May; 22(1):141. PubMed ID: 29843808 [TBL] [Abstract][Full Text] [Related]
3. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Corbella X; Pujol M; Ayats J; Sendra M; Ardanuy C; Domínguez MA; Liñares J; Ariza J; Gudiol F Clin Infect Dis; 1996 Aug; 23(2):329-34. PubMed ID: 8842272 [TBL] [Abstract][Full Text] [Related]
4. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. de Jonge E; Schultz MJ; Spanjaard L; Bossuyt PM; Vroom MB; Dankert J; Kesecioglu J Lancet; 2003 Sep; 362(9389):1011-6. PubMed ID: 14522530 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU]. Ma MY; Xu J; Yu N; Huang GM Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):686-9. PubMed ID: 24225215 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of selective decontamination on antimicrobial resistance. Hammond JM; Potgieter PD Crit Care Med; 1995 Apr; 23(4):637-45. PubMed ID: 7712753 [TBL] [Abstract][Full Text] [Related]
7. Microbiological surveillance during selective decontamination of the digestive tract (SDD). Saunders GL; Hammond JM; Potgieter PD; Plumb HA; Forder AA J Antimicrob Chemother; 1994 Oct; 34(4):529-44. PubMed ID: 7868405 [TBL] [Abstract][Full Text] [Related]
8. Selective decontamination of the digestive tract: effect of cessation of routine application at an ICU. Tissot van Patot HA; Leusink JA; Roodenburg J; de Jongh BM; Lau HS; de Boer S; de Boer A Pharm World Sci; 1996 Oct; 18(5):171-7. PubMed ID: 8933577 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
10. [Selective decontamination of the digestive tract reduces mortality in intensive care patients]. Rommes JH; Zandstra DF; van Saene HK Ned Tijdschr Geneeskd; 1999 Mar; 143(12):602-6. PubMed ID: 10321285 [TBL] [Abstract][Full Text] [Related]
11. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Daneman N; Sarwar S; Fowler RA; Cuthbertson BH; Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693 [TBL] [Abstract][Full Text] [Related]
12. Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD). de Jonge E; de Wilde RBP; Juffermans NP; Oostdijk EAN; Bernards AT; van Essen EHR; Kuijper EJ; Visser CE; Kesecioglu J; Bonten MJM Crit Care; 2018 Sep; 22(1):243. PubMed ID: 30268133 [TBL] [Abstract][Full Text] [Related]
13. Colistin and tobramycin resistance during long- term use of selective decontamination strategies in the intensive care unit: a post hoc analysis. Wittekamp BH; Oostdijk EA; de Smet AM; Bonten MJ Crit Care; 2015 Mar; 19(1):113. PubMed ID: 25880968 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. Ayats J; Corbella X; Ardanuy C; Domínguez MA; Ricart A; Ariza J; Martin R; Liñares J J Hosp Infect; 1997 Dec; 37(4):287-95. PubMed ID: 9457606 [TBL] [Abstract][Full Text] [Related]
15. The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study. Buitinck S; Jansen R; Rijkenberg S; Wester JPJ; Bosman RJ; van der Meer NJM; van der Voort PHJ Crit Care; 2019 Jun; 23(1):208. PubMed ID: 31174575 [TBL] [Abstract][Full Text] [Related]
16. Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial. Melsen WG; de Smet AM; Kluytmans JA; Bonten MJ; Br J Surg; 2012 Feb; 99(2):232-7. PubMed ID: 22021072 [TBL] [Abstract][Full Text] [Related]
17. Is there a role for selective decontamination of the digestive tract in primarily infected patients in the ICU? Hammond JM; Potgieter PD Anaesth Intensive Care; 1995 Apr; 23(2):168-74. PubMed ID: 7793587 [TBL] [Abstract][Full Text] [Related]
18. [Frequency of colonization and pneumonia and development of resistance in long-term ventilated intensive-care patients subjected to selective decontamination of the digestive tract]. Konrad F; Schwalbe B; Heeg K; Wagner H; Wiedeck H; Kilian J; Ahnefeld FW Anaesthesist; 1989 Mar; 38(3):99-109. PubMed ID: 2719231 [TBL] [Abstract][Full Text] [Related]
19. Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Oostdijk EA; Smits L; de Smet AM; Leverstein-van Hall MA; Kesecioglu J; Bonten MJ Intensive Care Med; 2013 Apr; 39(4):653-60. PubMed ID: 23203301 [TBL] [Abstract][Full Text] [Related]
20. Selective oropharyngeal decontamination versus selective digestive decontamination in critically ill patients: a meta-analysis of randomized controlled trials. Zhao D; Song J; Gao X; Gao F; Wu Y; Lu Y; Hou K Drug Des Devel Ther; 2015; 9():3617-24. PubMed ID: 26203227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]